Recombinant IL13R (Eblasakimab Biosimilar) antibody (PE)
The Human Monoclonal anti-IL13R (Eblasakimab Biosimilar) antibody is suitable to detect IL13R (Eblasakimab Biosimilar) in samples from Human. It has been validated for FACS.
Catalog No. ABIN7867314
$569.23
Plus shipping costs $50.00
100 tests
Shipping to:
United States
Delivery in 2 to 4 Business Days
Quick Overview for Recombinant IL13R (Eblasakimab Biosimilar) antibody (PE) (ABIN7867314)
Target
IL13R (Eblasakimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This IL13R (Eblasakimab Biosimilar) antibody is conjugated to PE
Application
Flow Cytometry (FACS)
-
-
Purpose
- PE-conjugated Anti-IL13RA1(eblasakimab biosimilar) mAb
-
Isotype
- IgG4
-
-
-
-
Application Notes
- Flow Cyt 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid PBS with 0.05 % Proclin300, 1 % BSA
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2°C-8°C for 6 months
-
Expiry Date
- 6 months
-
-
- IL13R (Eblasakimab Biosimilar)
-
Alternative Name
- eblasakimab biosimilar
-
Target Type
- Biosimilar
-
Background
-
Synonyms: IL13R, IL13RA, CD213a1, CT19,ASLAN004, ASLAN-004, CSL-334
Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
UniProt
- P78552
Target
-
You are here:
